Article Text
Statistics from Altmetric.com
The outcome of treatment for major depression is suboptimal. Only a minority of patients (<30%) achieve remission with the first antidepressant, and most relapse. Each subsequent treatment trial yields even lower rates of remission. Psychotherapy, similarly, results in a 30% remission rate and a 50% improvement in 50% of depressed patients. Between 15% and 30% of depressed patients have a chronic course of illness despite adequate treatment trials. There is, therefore, a well-established need for new approaches for depressed patients who have not responded well to commonly used antidepressant treatments.
The development of second-generation antipsychotic medications with arguably more benign side effect profiles has led to a renewed interest in their use for the treatment of depression. …
Footnotes
-
Competing interests None.
Request Permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.